GIT Tumors - Molecular Level 400
Exploring the molecular pathogenesis of esophageal, stomach and intestinal tumors
Quick Rules
-
Time limit: 20 minutes
-
Multiple attempts are not allowed
-
All questions must be answered to submit
Share Quiz
Quiz Questions Preview
Question 1
A 62-year-old male patient with a history of chronic gastroesophageal reflux disease (GERD) presents with progressive dysphagia and unintentional weight loss. Endoscopy reveals a mass in the lower esophagus, and biopsy indicates esophageal adenocarcinoma. Considering the patient’s background and typical progression, which factor is most likely contributing to the development of his cancer?
Explanation
Obesity-related gastroesophageal reflux disease is a major contributor to Barrett esophagus and subsequent esophageal adenocarcinoma. The other options, while relevant in various contexts, do not align as closely with the risk factors specific to esophageal adenocarcinoma in this scenario.
Question 2
A 45-year-old female presents with persistent dyspeptic symptoms and symptoms similar to chronic gastritis. Upon further examination, a diagnosis of gastric adenocarcinoma is confirmed, and genetic testing reveals a mutation in the CDH1 gene. Given this information, what is the most likely implication of this mutation regarding the patient's cancer prognosis?
Explanation
CDH1 mutations are associated with the diffuse type of gastric adenocarcinoma, which infiltrates the gastric wall and has a poorer prognosis due to its aggressive nature and late stage at diagnosis. The other answers downplay the significance of CDH1 mutations in gastric cancer.
Question 3
A 53-year-old male presents at the clinic with a 5-year history of progressively worsening dysphagia and weight loss. He has a long history of tobacco and alcohol use. A biopsy confirms esophageal squamous cell carcinoma, and imaging shows local lymph node involvement. Considering the patient's lifestyle and molecular pathogenesis, which intervention will most effectively improve his prognosis?
Explanation
Surgical resection is the most decisive treatment for esophageal squamous cell carcinoma when lymph nodes are involved and the patient is a candidate. Other options are useful adjuncts but don’t offer as definitive an improvement in survival.
Question 4
A pathologist analyzes a biopsy from a patient diagnosed with gastrointestinal stromal tumor (GIST). The results show a mutation in the KIT proto-oncogene. Considering the molecular biology of GISTs, which treatment would be most appropriate for this patient?
Explanation
Imatinib is an effective treatment for GISTs with KIT mutations as it specifically targets the aberrant signaling pathways activated by the mutation. The other options do not target the underlying molecular issue effectively.
Question 5
In a research study investigating the impacts of alcohol and tobacco use on esophageal cancer, the team identifies a cohort of African American males with high risk attributed to these factors. Which pathway of cancer development should receive the most focus in this population based on known risk factors?
Explanation
The synergistic effect of alcohol and tobacco use significantly increases the risk for esophageal squamous cell carcinoma, particularly in populations with high consumption rates. The other options are less relevant to the specific case.
Question 6
During an oncological evaluation, a family history of hereditary non-polyposis colorectal cancer (HNPCC) is revealed in a 30-year-old woman. Genetic tests confirm mutations in MSH2. Given this familial background, what initial cancer screening should be recommended for her?
Explanation
Due to her confirmed HNPCC and family history, heightened surveillance through more frequent colonoscopies is warranted, compared to the general population.
Question 7
A 48-year-old male presents with weight loss, fatigue, and early satiety, and endoscopic evaluation shows thickened gastric walls. Biopsy results confirm diffuse gastric adenocarcinoma. Considering the genetic implications, which factor will most significantly influence the treatment plan?
Explanation
The presence of E-cadherin loss linked to CDH1 mutations directly impacts the aggressiveness of the tumor and informs treatment decisions given the associated poor prognosis.
Question 8
In a clinical trial aimed at understanding the effects of diet on gastric cancer, a cohort is identified with a high incidence of gastric adenocarcinoma linked to low intake of fruits and vegetables. What public health strategy is most appropriate to reduce cancer incidence in this population?
Explanation
Targeting dietary deficiencies is a proactive strategy that addresses the identified risk factor linked to gastric cancer incidence, whereas the other options do not directly mitigate the dietary issue.
Question 9
A pathologist is evaluating gastric MALT lymphoma in a patient with chronic gastritis associated with H. pylori infection. Genetic analyses reveal translocations typical of MALT lymphomas. What is the best management approach for this patient?
Explanation
H. pylori eradication is a crucial step as this can lead to regression of gastric MALT lymphoma, which is often associated with chronic inflammation due to the infection.
Question 10
During a case study discussion, a team encounters a patient who developed esophageal adenocarcinoma without prior Barrett esophagus diagnosis. The patient’s lifestyle included significant obesity and a sedentary lifestyle. What conclusion can be drawn regarding the malignancy's development?
Explanation
Obesity can contribute to gastroesophageal reflux disease, increasing the risk for esophageal adenocarcinoma even in the absence of Barrett esophagus. It is a well-established link in cancer development.
Question 11
A 70-year-old male with a long-standing history of achalasia presents with dysphagia and esophageal pain. Endoscopic findings suggest esophageal squamous cell carcinoma. Understanding that achalasia is a risk factor for this type of cancer, which intervention should the healthcare team prioritize for initial management?
Explanation
Evaluating the patient for surgical intervention is crucial, as surgical removal can provide the best chance for treatment, especially when the cancer is localized.
Question 12
In a recent study, a cohort of patients diagnosed with MALT lymphoma has been analyzed. Many exhibit specific genetic translocations associated with this type of lymphoma. Given this genetic backdrop, which of the following observations is most relevant to treatment prognosis?
Explanation
Translocations, particularly t(11;18)(q21;q21), are important as they can indicate a specific treatment response, especially concerning H. pylori involvement.
Question 13
During a diagnostic session, a pathologist encounters a patient with early-stage gastric adenocarcinoma. The tumor exhibits characteristics associated with the intestinal type. When developing a treatment plan, which molecular pathway should be targeted for optimal management?
Explanation
The intestinal type of gastric adenocarcinoma is closely related to mutations affecting the APC/β-catenin pathway, making it the primary target for intervention in this management scenario.
Question 14
In the evaluation of a cohort diagnosed with colorectal cancer, researchers note higher incidence rates of tumors with microsatellite instability (MSI-H). If a patient presents with signs consistent with Lynch syndrome, what screening intervention should be primarily considered due to the potential for early detection?
Explanation
For patients with Lynch syndrome, enhanced screening protocols are vital to enable the early detection of colorectal cancer, significantly lowering mortality rates associated with late-stage diagnoses.
Question 15
A 60-year-old male patient presents with dysphagia and significant weight loss. He has a history of long-standing reflux and Barrett's esophagus. Recent biopsies reveal progression to esophageal adenocarcinoma. Given his risk factors and current diagnosis, what is the most appropriate next step in management?
Explanation
The correct approach is to refer the patient for endoscopic ultrasound, which helps assess the depth of invasion and lymph node involvement, crucial for staging. Immediate chemotherapy without evaluation could lead to suboptimal treatment. A CT scan may miss localized disease information. Dietary advice is complementary but not urgent in this context.
Question 16
A 50-year-old woman from a rural area presents with esophageal cancer, and her history includes significant alcohol consumption and poverty. Upon review of her diet, she is noted to consume primarily hot beverages and low vegetable intake. What is the most significant risk factor contributing to her condition?
Explanation
The most significant risk factor is the consumption of very hot beverages, a known contributor to esophageal squamous cell carcinoma particularly in her demographic. While other factors are relevant, they do not have as direct an association as hot beverage consumption.
Question 17
An oncologist is managing a patient diagnosed with gastric adenocarcinoma. Genetic testing reveals a germline loss-of-function mutation in the CDH1 gene. What should the clinician advise regarding potential surveillance for neoplasms in this patient?
Explanation
The correct approach is to initiate regular endoscopic surveillance, as mutations in the CDH1 gene significantly increase the risk of diffuse gastric cancer. Neglecting surveillance could result in late-stage diagnosis. Genetic counseling is important but should not replace surveillance.
Question 18
In a study of a population residing in Iran with high rates of esophageal squamous cell carcinoma, researchers find significant cases linked to tobacco and alcohol use but also observe cases in non-smokers and non-drinkers. What should research consider as a significant contributor to esophageal cancer in this population?
Explanation
Inadequate dietary habits, especially low fruit and vegetable intake, are significant risk factors in developing esophageal cancer, even in individuals who do not use tobacco or consume alcohol. Other factors may contribute but do not represent the primary risk.
Question 19
A 45-year-old male presents with weight loss and anemia. His family history includes multiple relatives diagnosed with various cancers at young ages, suggesting a hereditary pattern. Genetic analysis reveals mutations in MSH2 associated with HNPCC. What is the best strategy to recommend for cancer screening in this patient?
Explanation
The best strategy is to begin screening colonoscopies at age 30 and every 1-2 years, as patients with HNPCC are at significantly increased risk for early colorectal cancer. Standard age recommendations are inappropriate here.
Question 20
During a tumor board meeting, a case of a patient with a GIST is presented. The biopsy indicates a mutation in the KIT gene. Which treatment strategy should the multidisciplinary team prioritize to manage this patient's condition effectively?
Explanation
The priority treatment strategy should be surgical resection as GISTs with KIT mutations often respond well to surgical intervention, particularly if localized. Chemotherapy and radiation are not primary approaches, and observation without intervention is not adequate in this context.